glp 1 ai GLP-1 Medications, Artificial Intelligence and Food Technology in 2025 AI-powered literature mining reveals the

Heart failure (HF) remains one of the cardiovascular diseases (CVDs) associated with a high unmet medical need due to high morbidity and mortality rates and ...

If we look at the numbers, the trajectory of GLP-1 (glucagon-like peptide-1) receptor agonists is not

GLP-3 RT triple GLP-1/GIP/glucagon agonist research peptide

Here the authors show the efficacy of GLP1-based multi-agonists, and superiority of GLP1/E, for managing metabolic complications of PCOS in preclinical models, with improvement also of some reproductive traits.

At 28.5 billion CFUs upon manufacture (at least 15 billion CFUs upon expiration), our capsules contain 5 strains that were carefully selected for their potential to aid in weight loss, fat tissue mass reduction, and maintenance of intestinal health

Background Limited data are available on the risk of pancreatic adverse events among people with obesity or type 2 diabetes mellitus (T2DM) initiating glucagon-like peptide-1 receptor agonist (GLP-1 RA)